Table 2 Characteristics of the 201 HIV/HCV-coinfected patients, who underwent liver biopsies.

No. HIV-1 patients *

Sex (male) *

Age (years) ^†

HIV acquired by IVDU *

Prior AIDS *

Years since HCV infection ^{†, ‡}

High alcohol intake ^{*, §}

Antiretroviral therapy

   Non treated *

   PI-based *

   NNRTI-based *

   3 NRTI-based *

   Other *

   Months on HAART (n = 190) ^†

Stage of liver fibrosis *

F0

F1

F2

F3

F4

Fibrosis progression index ^†

HIV markers

   Nadir CD4+ T-cells ^†

   Baseline CD4+ T-cells/μL ^†

   HIV-RNA < 50 cp/mL *

   Log10 VL copies/mL (n = 45)

HCV markers *

   HCV genotype

1 or 4

3

   HCV-RNA >850,000 cp/ml

Hematologic parameters ^†

   Platelet count (× 10 ⁹ /L)

   Fibrinogen (mg/dL)

   INR

Biochemical parameters ^†

   ALP (IU/L)

   AST (IU/L)

   GGT (IU/L)

   ALT (IU/L)

   AST/ALT